Clinical Trials Logo

Clinical Trial Summary

Tracheostomized patients in the ICU can have excessive tracheal secretions due to various causes as hyperactive airway, irritation of the mucus producing cells and inhibition of the ciliary functions. Excessive secretions will necessitate frequent suctions which carries the risk of tracheostomy tube obstruction if not managed properly. Excessive tracheal secretions may prolong the ICU stay, increase the nurses workload and increase patients morbidity and mortality.

This clinical trial hypothesizes that the use of glycopyrrolate may decrease the tracheal secretions and hence avoid such complications.

Clinical Trial Description

Patients fulfilling the inclusion criteria will be randomly assigned into one of 2 groups:

Group G (Intervention group): Patients will receive Glycopyrrolate 0.2 mg IV every 8 hours.

Group C (Control group): Patients will receive 2 mL Normal saline every 8 hours.

Both injections will be labelled as drug A and drug B in the satellite pharmacy .

Both the attending physician, nurse and data collector will be blinded to the injection given.

Measurements data will be collected and recorded daily in the pre-prepared CRF during the study period. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04554589
Study type Interventional
Source Tanta University
Contact Mohammed Abosamak, MD
Phone 00966599056616
Status Not yet recruiting
Phase Phase 1
Start date September 14, 2020
Completion date April 10, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03683953 - The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells Phase 1
Completed NCT04170088 - Comparison of Efficacy of Tranexamic Acid Mesotherapy Versus 0.9% Normal Saline for Melasma Phase 2/Phase 3
Suspended NCT03995004 - The Effect of Melatonin on Postoperative Pain Reduction After Orthognathic Surgery Phase 1
Not yet recruiting NCT04110808 - Comparative Effect of Hypotensive Anaesthesia on Event Related Potentials, Quantitative Electroencephalograghy Early Phase 1
Terminated NCT04296838 - Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF Phase 2/Phase 3
Recruiting NCT03791372 - Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy Phase 1
Completed NCT04027543 - Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study)
Not yet recruiting NCT03696745 - The Treatment of Premature Infants With Brain Injury by Autologous Umbilical Cord Blood Stem Cells Phase 1
Recruiting NCT03120273 - A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults(Part 2) Phase 1
Unknown status NCT01633099 - Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients Phase 3
Completed NCT05311540 - Zinc Supplementation In Very Low Birth Weight Infants-A Randomised Controlled Trial Phase 4
Completed NCT03488186 - PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers Phase 1
Recruiting NCT04042597 - Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma Phase 2
Completed NCT03339882 - Remifemin Preventing the Climacteric Symptoms in Breast Cancer Phase 2
Completed NCT03760900 - Safety of Autologous Cord Blood Cells for Preterm Infants. Early Phase 1
Recruiting NCT03053076 - Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates Phase 1
Recruiting NCT04326504 - Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil
Recruiting NCT03700177 - Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block Phase 4
Completed NCT03228836 - Efficacy and Safety Evaluation of IBI308 in Patients With Extranodal NK/T Cell Lymphoma Patients Phase 2
Not yet recruiting NCT03600506 - Dexmedetomidine Adjuvant to General Anesthesia of Abdominal Hysterectomy N/A